Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis.
Por:
Arvaniti P, Rodríguez-Tajes S, Padilla M, Olivas I, Mauro E, El Maimouni C, Lytvyak E, Verhelst X, Engel B, Taubert R, Lorente-Pérez S, Conde I, Riveiro-Barciela M, Ruiz-Cobo JC, Álvarez-Navascués C, Salcedo M, Gómez J, Janik MK, Mateos B, Efe C, Granito A, Dajti E, Azzaroli F, Horta D, Vila C, Castello I, Pérez-Medrano I, Arencibia A, Gerussi A, Bruns T, Colaprieto F, Lleo A, Van den Ende N, Verbeek J, Díaz-González Á, Morillas RM, Torner-Simó M, Bernal V, Fernández EM, Gevers TJG, Terziroli Beretta-Piccoli B, Gómez E, Cuenca P, de Boer YS, Kerkar N, Assis DN, Liberal R, Drenth JPH, Tana MM, Sebode M, Schregel I, Schramm C, Lohse AW, Montano-Loza AJ, Zachou K, Villamil A, Dalekos GN and Londoño MC
Publicada:
1 abr 2026
Ahead of Print:
8 abr 2025
Resumen:
BACKGROUND & AIMS: Management of patients with autoimmune hepatitis (AIH)-related decompensated cirrhosis is challenging because of the risk of treatment-related complications and lack of clinical recommendations. We investigated the predictive factors for treatment benefit in AIH-related decompensated cirrhosis at diagnosis and developed an algorithm to guide treatment decisions in clinical practice. METHODS: This retrospective, international, multicenter study included 232 patients with histologically confirmed AIH-related decompensated cirrhosis at diagnosis. The sub-hazard ratio (SHR) of mortality was determined by competing risk analysis, considering liver transplantation (LT) as competing event. A decision tree analysis was used to develop a treatment algorithm. RESULTS: At diagnosis, 89% of patients had ascites, and 41% had overt hepatic encephalopathy (OHE). Treated patients (n = 214; 92%) had higher aminotransferases, bilirubin, and modified hepatic activity index. The SHR of mortality was lower in treated patients (0.438; 95% confidence interval [CI], 0.196-0.981; P = .045). Patients without OHE grade 3/4 and Model for End-Stage Liver Disease-Sodium (MELD-Na) =28 at diagnosis were more likely to benefit from treatment. In these patients, a decline in MELD-Na =11 after 4 weeks of treatment had a 100% negative predictive value for death/LT. Forty-nine percent of treated patients recompensated during follow-up. Twenty percent of patients had to discontinue treatment, 65% during the first 4 weeks, and only 4% due to infectious complications. OHE =grade 2 and MELD-Na at diagnosis predicted the need for treatment discontinuation. CONCLUSIONS: Immunosuppression is beneficial in patients with AIH-related decompensated cirrhosis and active disease. OHE and MELD-Na at diagnosis, along with a decline in MELD-Na at 4 weeks of treatment, are the most important determinants of outcome and can guide treatment decisions.
Filiaciones:
Arvaniti P:
Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain
Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Rodríguez-Tajes S:
Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Padilla M:
Unidad de Autoinmunidad Hepática Sección de Hepatología y Trasplante Hepático, Hospital Italiano de Buenos Aires, Argentina
Olivas I:
Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Mauro E:
Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain
El Maimouni C:
Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain
Lytvyak E:
Division of Gastroenterology and Liver Unit, University of Alberta, Edmonton, Alberta, Canada
Verhelst X:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Gastroenterology and Hepatology, Liver Research Center, Ghent University Hospital, Ghent, Belgium
Engel B:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hannover, Germany
Taubert R:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hannover, Germany
Lorente-Pérez S:
Servicio de Hepatología, Hospital Clínico Lozano Blesa, Universidad de Zaragoza, Zaragoza, Spain
Conde I:
Unit of Hepatology and Liver Transplantation, University Hospital La Fe. Institute of Sanitary Investigation, La Fe, Valencia, Spain
Riveiro-Barciela M:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Liver Unit, Department of Internal Medicine, University Hospital Vall de Hebron, Barcelona, Spain
Ruiz-Cobo JC:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Liver Unit, Department of Internal Medicine, University Hospital Vall de Hebron, Barcelona, Spain
Álvarez-Navascués C:
Servicio de Aparato Digestivo, Hospital Universitario Central de Asturias, Oviedo, Spain
Salcedo M:
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Sección de Hepatología, Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Gómez J:
Servicio de Aparato Digestivo, Hospital Universitario de Burgos, Burgos, Spain
Janik MK:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Hepatology, Transplantology, and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
Mateos B:
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Servicio de Aparato Digestivo, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
Efe C:
Department of Gastroenterology, Harran University, Sanliurfa, Turkey
Granito A:
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Center for the Study and Treatment of Autoimmune Diseases of the Liver and Biliary System, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
Dajti E:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Gastroenterology Units, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Azzaroli F:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Gastroenterology Units, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Horta D:
Servicio de Aparato Digestivo, Hospital Universitario Mutua de Terrassa, Terrassa, Spain
Vila C:
Servicio Digestivo (Endumsalut), Hospital Universitario Quirón Dexeus, Barcelona, Spain
Castello I:
Servicio de Aparato Digestivo, Hospital General Universitario de Valencia, Valencia, Spain
Pérez-Medrano I:
Complexo Hospitalario Universitario de Pontevedra, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Pontevedra, Spain
Arencibia A:
Servicio de Aparato Digestivo, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain
Gerussi A:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza (MB), Italy
Bruns T:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Medicine III, University Hospital RWTH Aachen, European Reference Network on Liver Disease (ERN Rare-Liver), Aachen, Germany
Colaprieto F:
Department of Biomedical Sciences, Humanitas University, Milan, Italy
Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy
Lleo A:
Department of Biomedical Sciences, Humanitas University, Milan, Italy
Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano, Italy
Van den Ende N:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Gastroenterology and Hepatology, University Hospitals KU Leuven, Leuven, Belgium
Verbeek J:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Gastroenterology and Hepatology, University Hospitals KU Leuven, Leuven, Belgium
Díaz-González Á:
Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases Group, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain
:
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Department of Hepatology, Hospital Germans Trias i Pujol, Institute of Investigation Germans Trias i Pujol (IGTP), Badalona, Spain
Torner-Simó M:
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Department of Hepatology, Hospital Germans Trias i Pujol, Institute of Investigation Germans Trias i Pujol (IGTP), Badalona, Spain
Bernal V:
Servicio de Aparato Digestivo, Hospital Universitario Miguel Servet, Zaragoza, Spain
Fernández EM:
Servicio de Aparato Digestivo, Hospital Universitario Miguel Servet, Zaragoza, Spain
Gevers TJG:
Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands
Terziroli Beretta-Piccoli B:
Facoltà di Scienze Biomediche, Università della Svizzera Italiana, Epatocentro Ticino, Lugano, Switzerland
Gómez E:
Servicio de Aparato Digestivo, Hospital Universitario 12 de Octubre, Madrid, Spain
Cuenca P:
Servicio de Aparato Digestivo, Hospital Clínico San Carlos, Madrid, Spain
de Boer YS:
Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands
Kerkar N:
Division of Gastroenterology, Hepatology, and Nutrition, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, Section of Pediatric Hepatology and Liver Transplantation, Massachusetts General Hospital for Children, Harvard University, Boston, Massachusetts
Assis DN:
Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut
Liberal R:
Gastroenterology Department, Centro Hospitalar Universitário de São João, Facultyof Medicine of the University of Porto, Porto, Portugal
Drenth JPH:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands
Tana MM:
Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, California
Sebode M:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
Schregel I:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
Schramm C:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Lohse AW:
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
Montano-Loza AJ:
Division of Gastroenterology and Liver Unit, University of Alberta, Edmonton, Alberta, Canada
Zachou K:
Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Villamil A:
Unidad de Autoinmunidad Hepática Sección de Hepatología y Trasplante Hepático, Hospital Italiano de Buenos Aires, Argentina
Dalekos GN:
Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Londoño MC:
Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain
European Reference Network on Hepatological Diseases (ERN RARE-LIVER)
Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Green Submitted
|